Certain Common Stock of Intra-Cellular Therapies, Inc. are subject to a Lock-Up Agreement Ending on 6-MAR-2022. These Common Stock will be under lockup for 61 days starting from 4-JAN-2022 to 6-MAR-2022.

Details:
The executive officers and directors and the stockholders of company's outstanding securities have agreed that they will not offer, sell, contract to sell, pledge, or otherwise dispose of, directly or indirectly, or hedge our units, warrants, shares or any other securities convertible into or exchangeable or exercisable for company's common shares, for a period of 60 days after the date of the final prospectus without the prior written consent of J.P. Morgan Securities LLC and SVB Leerink LLC.